Sophie has an MEng and aPhD in Biotechnology at UTC Compiègne, and also holds a HEC MBA. She is a medtech entrepreneur, and has previously been General Manager of Livanova France & UK, CCO of Mauna Kea technologies and CEO of Cellnovo. She now is a partner at Agile Capital Markets.